[Diabetes and the metabolic syndrome].
Yamauchi
Toshimasa
T
tyamau-tky@umin.ac.jp
Kadowaki
Takashi
T
D000818:Animals; D050882:CREB-Binding Protein / Q000502:physiology; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000209:etiology; D004041:Dietary Fats / Q000009:adverse effects; D004734:Energy Metabolism; D005230:Fatty Acids, Nonesterified / Q000009:adverse effects; D051275:Glucose Transporter Type 4 / Q000502:physiology; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics; D020738:Leptin / Q000502:physiology; D024821:Metabolic Syndrome / Q000209:etiology; D047495:PPAR gamma / Q000819:agonists / Q000502:physiology; D054419:Receptors, Adiponectin; D011956:Receptors, Cell Surface / Q000502:physiology; D052243:Resistin / Q000502:physiology; D012177:Retinol-Binding Proteins / Q000502:physiology; D054839:Retinol-Binding Proteins, Plasma; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
C475418:ADIPOR1 protein, human; D004041:Dietary Fats; D005230:Fatty Acids, Nonesterified; D051275:Glucose Transporter Type 4; D020738:Leptin; D047495:PPAR gamma; C101326:RBP4 protein, human; D054419:Receptors, Adiponectin; D011956:Receptors, Cell Surface; D052243:Resistin; D012177:Retinol-Binding Proteins; D054839:Retinol-Binding Proteins, Plasma; D014409:Tumor Necrosis Factor-alpha; D050882:CREB-Binding Protein